October 16, 2012
$30.9M Series B Investment closed and Joel Martin appointed as President and CEO
September 07, 2011
Cebix to Chair Symposium on C-Peptide and the Pathophysiology of Diabetes at European Association for the Study of Diabetes Annual Meeting 2011
There are no clinical trials enrolling at this time. Please check back in 2015.